Healthcare provider profile · identity verified

Clement C. Au, M.D.

Family Practice · PALM DESERT, CA · NPI 1487674701

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	433	133
Losartan Potassium	Losartan Potassium	357	103
Levothyroxine Sodium	Levothyroxine Sodium	311	87
Amlodipine Besylate	Amlodipine Besylate	293	88
Rosuvastatin Calcium	Rosuvastatin Calcium	198	65
Tamsulosin Hcl	Tamsulosin Hcl	191	65
Omeprazole	Omeprazole	185	60
Alprazolam	Alprazolam	181	42
Metoprolol Succinate	Metoprolol Succinate	157	49
Gabapentin	Gabapentin	139	46
Lisinopril	Lisinopril	134	37
Pantoprazole Sodium	Pantoprazole Sodium	120	39
Alendronate Sodium	Alendronate Sodium	117	40
Ozempic	Semaglutide	98	15
Allopurinol	Allopurinol	93	25
Eliquis	Apixaban	93	29
Zolpidem Tartrate	Zolpidem Tartrate	92	43
Meloxicam	Meloxicam	87	35
Simvastatin	Simvastatin	87	26
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	84	20
Mounjaro	Tirzepatide	84	11
Jardiance	Empagliflozin	83	22
Hydrochlorothiazide	Hydrochlorothiazide	77	23
Finasteride	Finasteride	75	23
Metformin Hcl	Metformin Hcl	63	19
Escitalopram Oxalate	Escitalopram Oxalate	61	18
Trazodone Hcl	Trazodone Hcl	60	23
Sertraline Hcl	Sertraline Hcl	57	17
Valsartan	Valsartan	56	17
Montelukast Sodium	Montelukast Sodium	55	19
Synthroid	Levothyroxine Sodium	55	14
Carvedilol	Carvedilol	50	14
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	50	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	47	16
Naproxen	Naproxen	47	13
Pravastatin Sodium	Pravastatin Sodium	47	13
Doxepin Hcl	Doxepin Hcl	46	20
Lorazepam	Lorazepam	44	16
Metformin Hcl Er	Metformin Hcl	44	14
Duloxetine Hcl	Duloxetine Hcl	43	15
Ezetimibe	Ezetimibe	41	12
Paxlovid	Nirmatrelvir/Ritonavir	39	37
Albuterol Sulfate Hfa	Albuterol Sulfate	38	18
Benazepril Hcl	Benazepril Hcl	38	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	33
Fluticasone Propionate	Fluticasone Propionate	38	11
Trulicity	Dulaglutide	37	suppressed
Azelastine Hcl	Azelastine Hcl	36	suppressed
Clopidogrel	Clopidogrel Bisulfate	36	suppressed
Furosemide	Furosemide	36	12
Tramadol Hcl	Tramadol Hcl	36	20
Citalopram Hbr	Citalopram Hydrobromide	35	11
Famotidine	Famotidine	33	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	33	26
Farxiga	Dapagliflozin Propanediol	32	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	31	29
Potassium Chloride	Potassium Chloride	28	suppressed
Rybelsus	Semaglutide	28	suppressed
Valacyclovir	Valacyclovir Hcl	28	16
Xarelto	Rivaroxaban	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Atenolol	Atenolol	26	suppressed
Prednisone	Prednisone	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	26	suppressed
Diazepam	Diazepam	25	suppressed
Breo Ellipta	Fluticasone/Vilanterol	24	suppressed
Ipratropium Bromide	Ipratropium Bromide	24	13
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Flecainide Acetate	Flecainide Acetate	21	suppressed
Memantine Hcl	Memantine Hcl	21	suppressed
Mirtazapine	Mirtazapine	21	suppressed
Temazepam	Temazepam	21	suppressed
Bupropion Xl	Bupropion Hcl	20	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	19	suppressed
Cephalexin	Cephalexin	19	19
Chlorthalidone	Chlorthalidone	19	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	18	suppressed
Baclofen	Baclofen	17	suppressed
Ketoconazole	Ketoconazole	17	12
Propranolol Hcl Er	Propranolol Hcl	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	13
Glipizide	Glipizide	16	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	14	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	14	suppressed
Dutasteride	Dutasteride	13	suppressed
Linzess	Linaclotide	13	suppressed
Methylprednisolone	Methylprednisolone	13	12
Movantik	Naloxegol Oxalate	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Paxlovid (Eua)	Nirmatrelvir/Ritonavir	13	13
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Klor-Con	Potassium Chloride	12	suppressed
Lactulose	Lactulose	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Mupirocin	Mupirocin	12	suppressed
Ondansetron Hcl	Ondansetron Hcl	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Xultophy 100-3.6	Insulin Degludec/Liraglutide	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	11	suppressed
Clonazepam	Clonazepam	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Lovastatin	Lovastatin	11	suppressed
Terazosin Hcl	Terazosin Hcl	11	suppressed
Testosterone	Testosterone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error